BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 22, Issue 1
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (13777)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.
Item 
Count 
PDF1310
WORD288
HTML8568
Figures (1-1)255
 Sum=10421
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1522
Download1828
 Sum=3350
Jan 7, 2016 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Song PP, Xia JF, Inagaki Y, Hasegawa K, Sakamoto Y, Kokudo N, Tang W. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 262-274 [PMID: 26755875 DOI: 10.3748/wjg.v22.i1.262]
URL: https://www.wjgnet.com/1007-9327/full/v22/i1/262.htm
Number Citing Articles
1
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032
2
Tengfei Si, Zhenlin Huang, Yuanhang Jiang, Abigail Walker-Jacobs, Shaqira Gill, Robert Hegarty, Mohammad Hamza, Shirin Elizabeth Khorsandi, Wayel Jassem, Nigel Heaton, Yun Ma. Expression Levels of Three Key Genes CCNB1, CDC20, and CENPF in HCC Are Associated With Antitumor Immunity. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.738841
3
Misu Lee, Haeyong Ko, Mijin Yun. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma. Yonsei Medical Journal 2018; 59(10): 1143 doi: 10.3349/ymj.2018.59.10.1143
4
Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Gi Soo Youn, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Dong Joon Kim, Tae-Jin Kim, Ki Tae Suk. Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications. International Journal of Molecular Sciences 2021; 22(3): 1160 doi: 10.3390/ijms22031160
5
David J. Pinato, Alessia Dalla Pria, Rohini Sharma, Mark Bower. Hepatocellular carcinoma. AIDS 2017; 31(5): 603 doi: 10.1097/QAD.0000000000001422
6
Yigan Zhang, Huaze Xi, Xin Nie, Peng Zhang, Ning Lan, Ying Lu, Jinrong Liu, Wenzhen Yuan. Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases. Current Drug Metabolism 2019; 20(10): 785 doi: 10.2174/1389200220666191011120434
7
Mirela Georgiana Perne, Adela-Viviana Sitar-Tăut, Teodora Gabriela Alexescu, Lorena Ciumărnean, Mircea-Vasile Milaciu, Sorina-Cezara Coste, Calin-Vasile Vlad, Angela Cozma, Dan-Andrei Sitar-Tăut, Olga Hilda Orăşan, Alexandra Crăciun. Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Diagnostics 2023; 13(5): 816 doi: 10.3390/diagnostics13050816
8
Huiying Liu, Jianjun Zhu, Lingling Guo, Hongjuan Zhang, Shuxiong Liu, Xiaoxia Kou, Zhiqian Zhang. Identification of a Two-lncRNA Signature with Prognostic and Diagnostic Value for Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/2687455
9
Chunmeng Wei, Yasi Li, Kaiming Huang, Gang Li, Min He. Exosomal miR-1246 in Body Fluids is a Potential Biomarker for Gastrointestinal Cancer. Biomarkers in Medicine 2018; 12(10): 1185 doi: 10.2217/bmm-2017-0440
10
Chansik An, Do Young Kim, Jin-Young Choi, Kwang Hyub Han, Yun Ho Roh, Myeong-Jin Kim. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4827-2
11
Ismail Shah, Sajjad Ali Khan, Sadiq Hussain, Fazlullah Khan, Kamal Niaz. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021; : 105 doi: 10.1016/B978-0-12-816488-4.00004-8
12
Josep M. Llovet, Amit G. Singal, Augusto Villanueva, Richard S. Finn, Masatoshi Kudo, Peter R. Galle, Masafumi Ikeda, Sophie Callies, Louise M. McGrath, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Elena Gonzalez-Gugel, Andrew X. Zhu. Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials. Clinical Cancer Research 2022; 28(11): 2297 doi: 10.1158/1078-0432.CCR-21-4000
13
Pei-Wei Yang, Ting-Ting Chen, Wen-Xia Zhao, Guang-Wei Liu, Xiao-Jun Feng, Shou-Mei Wang, Yun-Cui Pan, Qian Wang, Shu-Hui Zhang. Scutellaria barbata D.Don and Oldenlandia diffusa (Willd.) Roxb crude extracts inhibit hepatitis-B-virus-associated hepatocellular carcinoma growth through regulating circRNA expression. Journal of Ethnopharmacology 2021; 275: 114110 doi: 10.1016/j.jep.2021.114110
14
Fatemeh Nouri Rouz, Mohammad Shirkhoda, Feridon Memari, Hassan Dana, Ghanbar Mahmoodi C, Habibollah Mahmoodzad, Nasim Samarghand, Elahe Gharagozlo, Mohammad Hosein Mohammadi , Ali Reza Maleki, Ehsan Sadeghian, ElhamZainali Nia, Nedazainali Nia, Farimah Hadjilooei, Omid Rezaeian, Saeed Meghdadi, SeyedRohollah Miri, Fatameh Jafari, Elham Rayzan, Vahid Marmari. Immunotherapy a New Hope for Cancer Treatment: A Review. Pakistan Journal of Biological Sciences 2018; 21(3): 135 doi: 10.3923/pjbs.2018.135.150
15
Aly O. Aboelfotoh, Enas M. Foda, Ahmed M. Elghandour, Nahla M. Teama, Reham A. Abouzein, Ghada A. Mohamed. Talin-1; other than a potential marker for hepatocellular carcinoma diagnosis. Arab Journal of Gastroenterology 2020; 21(2): 80 doi: 10.1016/j.ajg.2020.04.017
16
Denghui Li. Potential therapies for HCC involving targeting the ferroptosis pathway. American Journal of Cancer Research 2024; 14(4): 1446 doi: 10.62347/SIGP9279
17
Taya Kitiyakara, Susan Redmond, Nattawut Unwanatham, Sasivimol Rattanasiri, Amarin Thakkinstian, Pongsatorn Tangtawee, Somkit Mingphruedhi, Abhasnee Sobhonslidsuk, Pongphob Intaraprasong, Chomsri Kositchaiwat. The detection of hepatocellular carcinoma (HCC) from patients’ breath using canine scent detection: a proof-of-concept study. Journal of Breath Research 2017; 11(4): 046002 doi: 10.1088/1752-7163/aa7b8e
18
Guillermo Aquino-Jarquin. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research. Cancer Research 2017; 77(24): 6812 doi: 10.1158/0008-5472.CAN-17-2142
19
Carolin Czauderna, Irene Schmidtmann, Sandra Koch, Lukas Pilz, Sophia Heinrich, Gerd Otto, Jens Mittler, Hauke Lang, Roman Kloeckner, Christoph Düber, Martin F. Sprinzl, Marcus A. Worns, Peter R. Galle, Jens U. Marquardt, Arndt Weinmann. High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma. United European Gastroenterology Journal 2021; 9(3): 388 doi: 10.1177/2050640620972611
20
Peng Gao, Xin Huang, Xue-Yan Fang, Hui Zheng, Shu-Ling Cai, Ai-Jun Sun, Liang Zhao, Yong Zhang. Application of metabolomics in clinical and laboratory gastrointestinal oncology. World Journal of Gastrointestinal Oncology 2021; 13(6): 536-549 doi: 10.4251/wjgo.v13.i6.536
21
Chaoran Zang, Yan Zhao, Ling Qin, Guihai Liu, Jianping Sun, Kang Li, Yanan Zhao, Shoupeng Sheng, Honghai Zhang, Ning He, Peng Zhao, Qi Wang, Xi Li, Yanchun Peng, Tao Dong, Yonghong Zhang. Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08720-9
22
Hsiao‐Chen Tu, Yung‐Chun Hsiao, Wan‐Yu Yang, Shin‐Lin Tsai, Hua‐Kuo Lin, Chong‐Yi Liao, Jeng‐Wei Lu, Yu‐Ting Chou, Horng‐Dar Wang, Chiou‐Hwa Yuh. Up‐regulation of golgi α‐mannosidase IA and down‐regulation of golgi α‐mannosidase IC activates unfolded protein response during hepatocarcinogenesis. Hepatology Communications 2017; 1(3): 230 doi: 10.1002/hep4.1032
23
Chia‐Jui Yen, Yu‐Lin Ai, Hung‐Wen Tsai, Shih‐Huang Chan, Chia‐Sheng Yen, Kuang‐Hsiung Cheng, Yun‐Ping Lee, Chia‐Wei Kao, Yu‐Chun Wang, Yi‐Lin Chen, Cheng‐Han Lin, Tsunglin Liu, Huey‐Pin Tsai, Jen‐Ren Wang, Ih‐Jen Su, Wenya Huang. Hepatitis B virus surface gene pre‐S2 mutant as a high‐risk serum marker for hepatoma recurrence after curative hepatic resection. Hepatology 2018; 68(3): 815 doi: 10.1002/hep.29790
24
Sanshun Zhou, Zusen Wang, Manjiang Li, Liqun Wu. Elevated Preoperative Serum CA125 Predicts Larger Tumor Diameter in Patients with Hepatocellular Carcinoma and Low AFP Levels. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/6959637
25
Zhigui Li, Xiaoting Wu, Tianfu Wen, Chuan Li, Wen Peng. Multiple ectopic hepatocellular carcinomas in the pancreas. Medicine 2017; 96(30): e6747 doi: 10.1097/MD.0000000000006747
26
Sven H. Loosen, Christoph Roderburg, Tom Luedde. Reply to: “Is osteopontin a promising prognostic biomarker for cholangiocarcinoma?”. Journal of Hepatology 2018; 68(1): 206 doi: 10.1016/j.jhep.2017.08.027
27
Charles C. Vining, Phillip J. Hsu, Darryl Schuitevoerder, Nora E. Joseph, Melissa E. Hogg. Robotic Distal Pancreatectomy and Splenectomy for an Intrapancreatic Hepatocellular Carcinoma: A Case Report and Review of the Literature. Journal of Pancreatic Cancer 2020; 6(1): 96 doi: 10.1089/pancan.2020.0009
28
Xiuping Li, Yuzhen Guo, Xiyan Wang, Anning Ge, Hui Wang, Kaiyun Fan, Changtong Guo. Clinical significance of serum miR-487b in HBV-related hepatocellular carcinoma and its potential mechanism. Infectious Diseases 2021; 53(7): 546 doi: 10.1080/23744235.2021.1901981
29
Dahn Byun, Seul Gi Lee, Hyeyoung Kim, Yunghun You, Jaehag Jung, Je Ho Jang, Moon-Soo Lee, Chang-Nam Kim, Byung Sun Cho, Yoon-Jung Kang. Prognostic value of preoperative protein-induced vitamin K absence or antagonist II after liver resection for hepatitis B-related hepatocellular carcinoma: a nationwide multicenter study. Annals of Surgical Treatment and Research 2022; 103(5): 271 doi: 10.4174/astr.2022.103.5.271
30
Jiu Chen, Guolin Wu, Youdi Li. Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/8906023
31
Nan-Ee Lee, Sun Hee Kim, Dae-Yeul Yu, Eui-Jeon Woo, Myung-Il Kim, Gi-Sang Seong, Sun Min Lee, Jeong-Heon Ko, Yong-Sam Kim. Aglycosylated antibody-producing mice for aglycosylated antibody-lectin coupled immunoassay for the quantification of tumor markers (ALIQUAT). Communications Biology 2020; 3(1) doi: 10.1038/s42003-020-01363-9
32
Saurabh K. Chhonker, Divya Rawat, Raj Kumar Koiri. Protective and therapeutic effects of sildenafil and tadalafil on aflatoxin B1-induced hepatocellular carcinoma. Molecular and Cellular Biochemistry 2021; 476(2): 1195 doi: 10.1007/s11010-020-03982-6
33
Wenying Qiao, Jiashuo Li, Yiqi Xiong, Jiasheng Zheng, Ronghua Jin, Caixia Hu. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation. Journal of Cancer Research and Clinical Oncology 2024; 150(5) doi: 10.1007/s00432-024-05760-z
34
Oraphan Jitpraphawan, Witchakorn Ruamtawee, Mala Treewatchareekorn, Supatsri Sethasine. Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study. World Journal of Gastroenterology 2024; 30(17): 2343-2353 doi: 10.3748/wjg.v30.i17.2343
35
Hager F. Ahmed Mohammed, Lewis R. Roberts. Should AFP (or Any Biomarkers) Be Used for HCC Surveillance?. Current Hepatology Reports 2017; 16(2): 137 doi: 10.1007/s11901-017-0349-7
36
Xiaonan Mao, Yan Guo, Zaiming Lu, Feng Wen, Hongyuan Liang, Wei Sun. Enhanced CT Textures Derived From Computer Mathematic Distribution Analysis Enables Arterial Enhancement Fraction Being an Imaging Biomarker Option of Hepatocellular Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01337
37
Jing Xie, Aihua Zhang, Xijun Wang. Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small molecules. RSC Advances 2017; 7(28): 17217 doi: 10.1039/C7RA00698E
38
Chyntia Olivia Maurine Jasirwan, Alessa Fahira, Lianda Siregar, Imelda Loho. The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01365-1
39
Samy Kashkoush, Sherif Saleh, Walid Elmoghazy. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_34-1
40
Huisi He, Shuzhen Chen, Zhecai Fan, Yaping Dong, Ying Wang, Shiyao Li, Xiaojuan Sun, Yuting Song, Jinxian Yang, Qiqi Cao, Jie Jiang, Xianming Wang, Wen Wen, Hongyang Wang. Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. Cell Discovery 2023; 9(1) doi: 10.1038/s41421-023-00563-x
41
Peipei Song, Qi Tang, Xiaobin Feng, Wei Tang. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma. Scandinavian Journal of Clinical and Laboratory Investigation 2016; 76(sup245): S70 doi: 10.1080/00365513.2016.1210328
42
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
43
Catharine Sturgeon. Standardization of tumor markers – priorities identified through external quality assessment. Scandinavian Journal of Clinical and Laboratory Investigation 2016; 76(sup245): S94 doi: 10.1080/00365513.2016.1210334
44
Samy Kashkoush, Sherif Saleh, Walid Elmoghazy. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 837 doi: 10.1007/978-94-007-7675-3_34
45
Jingjing Dai, Bo Yang, Abdusemer Reyimu, Weiqiang Li, Wubi Zhou, Xiang Wang, Weijie Dai, Wan Wang, Jianghong Yan, Suxia Hu. Establishment of prognosis model of hepatocellular carcinoma based on prognosis related gene analysis and study on gene regulation mechanism of model. Heliyon 2024; 10(21): e38729 doi: 10.1016/j.heliyon.2024.e38729
46
Shivani R Kale, Geeta Karande, Anand Gudur, Aishwarya Garud, Monika S Patil, Satish Patil. Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques. Cureus 2024;  doi: 10.7759/cureus.72239
47
Yongzhen Liu, Xuewei Qi, Zhenzhen Zeng, Lu Wang, Jie Wang, Ting Zhang, Qiang Xu, Congle Shen, Guangde Zhou, Shaomin Yang, Xiangmei Chen, Fengmin Lu. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03070-8
48
Paolo Magistri, Russell Rosenblatt, Karim J. Halazun. Liver Transplantation for HCC Beyond Milan. Current Transplantation Reports 2018; 5(4): 319 doi: 10.1007/s40472-018-0212-y
49
Vaneet Jearth, Prachi S. Patil, Shaesta Mehta, Sridhar Sundaram, Vishal Seth, Mahesh Goel, Shraddha Patkar, Munita Bal, Vidya Rao. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken. Journal of Clinical and Experimental Hepatology 2022; 12(3): 841 doi: 10.1016/j.jceh.2021.11.006
50
ZiHao Ni, BoLin Wu, Zhao Liu, QiuCheng Wang, Xue Han, Wen Cheng, CunLi Guo. Clinical value of combined preoperative–postoperative neutrophil-to-lymphocyte ratio in predicting hepatocellular carcinoma prognosis after radiofrequency ablation. The British Journal of Radiology 2023; 96(1145) doi: 10.1259/bjr.20220887
51
Ping Fang, Lijun Du, Decheng Cai. Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma. Medicine 2020; 99(12): e19461 doi: 10.1097/MD.0000000000019461
52
María Jesús Gaspar Blázquez, Jaume Trapé Pujol, Josep María Augé Fradera, Antonio Barco Sánchez, Rosa Carbonell Muñoz, Xavier Filella Pla, Antonio Fernández Suarez, Álvaro González Hernández, Antonio Martínez Peinado, Clara Pérez Barrios, Blanca Ortiz Muñoz, José Diego Santotoribio Camacho, Marta Sánchez-Carbayo, Rafael Molina Porto. Recomendaciones para la optimización del uso de marcadores tumorales de utilización frecuente. Recomendación (2018). Revista del Laboratorio Clínico 2019; 12(1): 38 doi: 10.1016/j.labcli.2018.09.002
53
Karolina Drozdzewska, Heidrun Gehlen. Markers for internal neoplasia in the horse. Veterinary Medicine and Science 2023; 9(1): 132 doi: 10.1002/vms3.1042
54
Chao-qun Li, Hui Huang, Si-min Ruan, Hang-tong Hu, Meng-fei Xian, Xiao-yan Xie, Ming-de Lu, Ming Kuang, Ying Wang, Li-da Chen. An assessment of liver lesions using a combination of CEUS LI-RADS and AFP. Abdominal Radiology 2022; 47(4): 1311 doi: 10.1007/s00261-022-03428-1
55
Yu Sun, Qing Wang, Yu Zhang, Mengyuan Geng, Yujuan Wei, Yanrui Liu, Shanshan Liu, Robert B. Petersen, Junqiu Yue, Kun Huang, Ling Zheng. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p. Journal of Hepatology 2020; 73(3): 603 doi: 10.1016/j.jhep.2020.03.050
56
Arndt Vogel, Tim Meyer, Gonzalo Sapisochin, Riad Salem, Anna Saborowski. Hepatocellular carcinoma. The Lancet 2022; 400(10360): 1345 doi: 10.1016/S0140-6736(22)01200-4
57
Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Kwang-Huei Lin. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma. Cells 2020; 9(2): 262 doi: 10.3390/cells9020262
58
Dou-Sheng Bai, Chi Zhang, Ping Chen, Sheng-Jie Jin, Guo-Qing Jiang. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-12834-1
59
Rahmi Oklu, Rahul Sheth, Hassan Albadawi, Irun Bhan, A. Fatih Sarioglu, Melissa Choz, Mahnaz Zeinali, Vikram Deshpande, Shyamala Maheswaran, Daniel A. Haber, Shannon L. Stott, Andrew X. Zhu, Lipika Goyal, Mehmet Toner, David T. Ting. Relationship between hepatocellular carcinoma circulating tumor cells and tumor volume. Cancer Convergence 2018; 2(1) doi: 10.1186/s41236-018-0009-z
60
Yahong Chen, Xueqing Yang, Xiawei Li. Impact of radiation therapy and alpha-fetoprotein level on survival outcomes for patients with hepatocellular carcinoma: A population-based study. Clinics and Research in Hepatology and Gastroenterology 2023; 47(8): 102196 doi: 10.1016/j.clinre.2023.102196
61
Jun Liu, Zhanzhong Ma, Yanming Liu, Liangyin Wu, Zhiwei Hou, Wenli Li. Screening of potential biomarkers in hepatitis C virus‑induced hepatocellular carcinoma using bioinformatic analysis. Oncology Letters 2019;  doi: 10.3892/ol.2019.10578
62
Wong Hoi She, Miu Yee Chan, Ka Wing Ma, Simon H. Y. Tsang, Wing Chiu Dai, Albert C. Y. Chan, Chung Mau Lo, Tan To Cheung. Alpha-Fetoprotein in Predicting Survival of Patients with Ruptured Hepatocellular Carcinoma after Resection. Journal of Investigative Surgery 2022; 35(5): 1091 doi: 10.1080/08941939.2021.2012615
63
Naoto Fujiwara, Po-Hong Liu, Sai Krishna Athuluri-Divakar, Shijia Zhu, Yujin Hoshida. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 3 doi: 10.1007/978-3-030-21540-8_1
64
Ye Shen, Juanjie Huang, Lei Jia, Chi Zhang, Jianxing Xu. Bioinformatics and machine learning driven key genes screening for hepatocellular carcinoma. Biochemistry and Biophysics Reports 2024; 37: 101587 doi: 10.1016/j.bbrep.2023.101587
65
Chloé Sauzay, Alexandra Petit, Anne-Marie Bourgeois, Jean-Claude Barbare, Bruno Chauffert, Antoine Galmiche, Aline Houessinon. Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. Clinica Chimica Acta 2016; 463: 39 doi: 10.1016/j.cca.2016.10.006
66
Jian Li, Tiezheng Wang, Boxun Jin, Wenlei Li, Zhenshun Wang, Haitao Zhang, Yunjun Song, Ning Li. Diagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma: a systematic review with meta-analysis. The International Journal of Biological Markers 2018; 33(4): 353 doi: 10.1177/1724600818784409
67
Omar Maddouri, Xiaoning Qian, Francis J. Alexander, Edward R. Dougherty, Byung-Jun Yoon. Robust importance sampling for error estimation in the context of optimal Bayesian transfer learning. Patterns 2022; 3(3): 100428 doi: 10.1016/j.patter.2021.100428
68
Nicolas Goossens, C. Billie Bian, Yujin Hoshida. Tailored Algorithms for Hepatocellular Carcinoma Surveillance: Is One-Size-Fits-All Strategy Outdated?. Current Hepatology Reports 2017; 16(1): 64 doi: 10.1007/s11901-017-0336-z
69
Salma Abdi Mahmoud, Mohammed Mohammed Ibrahim, Ahmed Hago Musa, Yuhong Huang, Jun Zhang, Jingwen Wang, Yuanyi Wei, Li Wang, Shunting Zhou, Boyi Xin, Wei Xuan, Jianwu Tang. Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin. Journal of Cell Communication and Signaling 2018; 12(3): 603 doi: 10.1007/s12079-017-0411-9
70
Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Maria Lorena Abate, Alessia Ciancio, Rinaldo Pellicano, Antonina Smedile, Giorgio Maria Saracco. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis. Scandinavian Journal of Gastroenterology 2018; 53(6): 734 doi: 10.1080/00365521.2018.1459824
71
Alejandra V. Contreras, Benjamin Cocom-Chan, Georgina Hernandez-Montes, Tobias Portillo-Bobadilla, Osbaldo Resendis-Antonio. Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine. Frontiers in Physiology 2016; 7 doi: 10.3389/fphys.2016.00606
72
Dan G. Duda, Simona O. Dima, Dana Cucu, Andrei Sorop, Sebastian Klein, Marek Ancukiewicz, Shuji Kitahara, Speranta Iacob, Nicolae Bacalbasa, Dana Tomescu, Vlad Herlea, Cristiana Tanase, Adina Croitoru, Irinel Popescu. Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients. Cancers 2020; 12(5): 1275 doi: 10.3390/cancers12051275
73
Dincer Ozgor, Emrah Otan. HCC and Tumor Biomarkers: Does One Size Fits All?. Journal of Gastrointestinal Cancer 2020; 51(4): 1122 doi: 10.1007/s12029-020-00485-x
74
Fumiko Chino, Sarah Jo Stephens, Steve S. Choi, Daniele Marin, Charles Y. Kim, Michael A. Morse, Devon J. Godfrey, Brian G. Czito, Christopher G. Willett, Manisha Palta. The role of external beam radiotherapy in the treatment of hepatocellular cancer. Cancer 2018; 124(17): 3476 doi: 10.1002/cncr.31334
75
Chang-Liang Luo, Yuan Rong, Hao Chen, Wu-Wen Zhang, Long Wu, Diao Wei, Xiu-Qi Wei, Lie-Jun Mei, Fu-Bing Wang. A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819846632
76
Roberta D'Ambrosio, Massimo Colombo. Should surveillance for liver cancer be modified in hepatitis C patients after treatment‐related cirrhosis regression?. Liver International 2016; 36(6): 783 doi: 10.1111/liv.13106
77
H Elalfy, T Besheer, MA El-Maksoud, K Farid, M Elegezy, AM El Nakib, MA El-Aziz, AA El-Khalek, A El-Morsy, A Elmokadem, AZ Elsamanoudy, M El-Bendary. Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization. British Journal of Biomedical Science 2018; 75(4): 187 doi: 10.1080/09674845.2018.1494769
78
Lijun Wan, Li Guo, Youwen Hu, Hongyan Huang, Moran Zhang, Kedong Xu, Gejirifu De, Fengfei Zheng, Zhengqiang Wu, Chungen Hu, Zhili Wen. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer. Clinical Biochemistry 2021; 89: 44 doi: 10.1016/j.clinbiochem.2020.12.005
79
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget 2017; 8(8): 14192 doi: 10.18632/oncotarget.13929
80
Vijay Pandyarajan, Rajalakshmi Govalan, Ju Dong Yang. Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(2): 479 doi: 10.3390/ijms22020479
81
Roshana Saghafian Larijani, Nazanin Shabani Ravari, Navid Goodarzi, Shahram Akhlaghpour, Samaneh Saghafian Larijani, Mohammad Reza Rouini, Rassoul Dinarvand. Current status of transarterial chemoembolization (TACE) agents in hepatocellular carcinoma treatment. Journal of Drug Delivery Science and Technology 2022; 77: 103905 doi: 10.1016/j.jddst.2022.103905
82
Alessandro Loglio, Massimo Iavarone, Floriana Facchetti, Dhanai Di Paolo, Riccardo Perbellini, Giovanna Lunghi, Ferruccio Ceriotti, Claudio Galli, Maria T. Sandri, Mauro Viganò, Angelo Sangiovanni, Massimo Colombo, Pietro Lampertico. The combination of PIVKA‐II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long‐term oral therapy. Liver International 2020; 40(8): 1987 doi: 10.1111/liv.14475
83
Varimadugu Aruna, A. Sneha, D. Sai Harshitha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 11 doi: 10.1016/B978-0-323-98806-3.00022-2
84
Hana Hadi, Wan Muhammad Azfar Wan Shuaib, Raja Affendi Raja Ali, Hanita Othman. Utility of PIVKA-II and AFP in Differentiating Hepatocellular Carcinoma from Non-Malignant High-Risk Patients. Medicina 2022; 58(8): 1015 doi: 10.3390/medicina58081015
85
Yoshimi Haga, Motohide Uemura, Satoko Baba, Kentaro Inamura, Kengo Takeuchi, Norio Nonomura, Koji Ueda. Identification of Multisialylated LacdiNAc Structures as Highly Prostate Cancer Specific Glycan Signatures on PSA. Analytical Chemistry 2019; 91(3): 2247 doi: 10.1021/acs.analchem.8b04829
86
Nan Zhang, Jiajia Gu, Li Yin, Jing Wu, Ming-yu Du, Kai Ding, Teng Huang, Xia He. Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database. Oncotarget 2016; 7(49): 81389 doi: 10.18632/oncotarget.13232
87
Basim Saleh Samman, Albadr Hussein, Razan Saleh Samman, Abdulaziz Saud Alharbi. Common Sensitive Diagnostic and Prognostic Markers in Hepatocellular Carcinoma and Their Clinical Significance: A Review. Cureus 2022;  doi: 10.7759/cureus.23952
88
Kim M. Olthoff, David S. Goldberg. The MoRAL Path Beyond Milan. Annals of Surgery 2016; 263(5): 851 doi: 10.1097/SLA.0000000000001679
89
Wasila Mansouri, Samuel B. Fordyce, Matthew Wu, David Jones, Douglas Cohn, Qishan Lin, Paul Feustel, Tanuj Sharma, James A. Bennett, Thomas T. Andersen. Efficacy and tolerability of AFPep, a cyclic peptide with anti-breast cancer properties. Toxicology and Applied Pharmacology 2018; 345: 10 doi: 10.1016/j.taap.2018.03.004
90
Naoto Fujiwara, Scott L. Friedman, Nicolas Goossens, Yujin Hoshida. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. Journal of Hepatology 2018; 68(3): 526 doi: 10.1016/j.jhep.2017.09.016
91
Jian-Ming Zhou, Ting Wang, Kun-He Zhang. AFP-L3 for the diagnosis of early hepatocellular carcinoma. Medicine 2021; 100(43): e27673 doi: 10.1097/MD.0000000000027673
92
Wai Yeow Lee, Maulana Bachtiar, Cheryl C. S. Choo, Caroline G. Lee. Comprehensive review of Hepatitis B Virus‐associated hepatocellular carcinoma research through text mining and big data analytics. Biological Reviews 2019; 94(2): 353 doi: 10.1111/brv.12457
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345